A once-controversial medical treatment is stepping back into the mainstream as new data reveals that the use of hormone therapy for menopause has nearly doubled over the past decade among American women. According to figures released by Epic Research analyzing outpatient data from over 163 million patients, usage climbed from 1.7 percent in January 2017 to approximately 3.6 percent by April 2026, driven by evolving scientific evidence, a surge in open discussions, and the removal of strict federal safety warnings.
Shifting Tides in Menopause Care and the FDA Decision
The landscape of women’s health underwent a major transformation following the Food and Drug Administration (FDA) decision in November 2025 to remove severe boxed warnings from estrogen-containing products. For years, following the landmark Women’s Health Initiative study in 2002, prescriptions had plateaued due to exaggerated fears of cardiovascular risks and breast cancer. However, updated reviews concluded those risks were overstated for women starting treatment near the onset of menopause. Dr. Adi Katz, director of benign gynecology at Northwell’s Lenox Hill Hospital, noted that removing the warning allows doctors and patients to have balanced conversations about actual risks and benefits.
Demographic Trends and Modern Treatment Methods
The study found that usage spiked sharply starting in 2023, with consumption nearly tripling among women aged 45 to 54, who typically experience perimenopause and menopause. Usage also doubled in cohorts aged 35 to 44 and 55 to 64. Furthermore, experts like Dr. Jessica Shepherd, a menopause expert and author of Generation M, point out that modern treatment is far more nuanced, with transdermal patches, gels, and targeted doses replacing rigid, one-size-fits-all approaches.
Empowering Women to Seek Relief
Medical professionals emphasize that while the therapy offers substantial long-term gains and relief from hot flashes and sleep disturbances, the decision must be individualized. Dr. Sherry Ross, an ob-gyn at Providence Saint John’s Health Center in Santa Monica, California, urges patients to stop fearing the treatment and openly discuss their symptoms and goals with healthcare providers to find the most appropriate and tailored care plan.
